期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌雌激素信号通路及维生素D对其影响的研究进展 被引量：3

原文传递
导出
摘要 目前，乳腺癌已成为女性中的第一大杀手。乳腺癌分为激素依赖型和激素非依赖型，激素依赖型乳腺癌其生长受到激素环境的影响，主要是雌激素。而激素非依赖型的乳腺癌其生长不受激素的调节，分化较差，愈后不佳。
作者 曹琳(综述) 郑维(审校)
机构地区 南华大学
出处 《中国医师杂志》 CAS 2013年第12期1723-1725,共3页 Journal of Chinese Physician
关键词 乳腺肿瘤 受体 雌激素 综述
分类号 R681 [医药卫生—骨科学]
  • 相关文献

参考文献24

  • 1Krishnan AV,Swami S,Feldman D. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer[J].{H}STEROIDS,2012,(11):1107-1112.
  • 2Krishnan AV,Swami S,Feldman D. Vitamin D and breast cancer:inhibition of estrogen synthesis and signaling[J].{H}Journal of Steroid Biochemistry and Molecular Biology,2010,(1-2):343-348.
  • 3孙丽芳,王建六,张丽丽,李小平,沈丹华.雌激素受体ERα36在子宫内膜癌组织中表达及临床意义的初步研究[J].现代妇产科进展,2011,20(2):97-100. 被引量：2
  • 4Borgquist S,Holm C,Stendahl M. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer[J].Clin Pathol,2008,(02):197-203.
  • 5Huang J,Li X,Yi P. Targeting estrogen responsive elements (EREs):design of potent transactivators for ERE-containing genes[J].{H}Molecular and Cellular Endocrinology,2004,(1-2):65-78.
  • 6Kushner PJ,Agard DA,Greene GL. Estrogen receptor pathways to AP-1[J].{H}Steriod Biochemistry and Molecular Biology,2000,(05):311-317.
  • 7Osborne CK,Schiff R. Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer[J].{H}BREAST,2003,(06):362-367.
  • 8Wang RA,Mazumdar A,Vadlamudi RK. P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium[J].{H}EMBO Journal,2002,(20):5437-5447.
  • 9Revankar CM,Cimino DF,Sklar LA. A transmembrane intracellular estrogen receptor mediates rapid cell signaling[J].{H}SCIENCE,2005,(5715):1625-1630.
  • 10Prossnitz ER,Maggiolini M. Mechanisms of estrogen signaling and gene expression via GPR30[J].{H}Molecular and Cellular Endocrinology,2009,(1-2):32-38.

二级参考文献35

  • 1黄文亭,冯一中,顾永平,柴玉海,李峰.TGF-β_1和CD105在胰腺癌中的表达及其临床意义[J].苏州大学学报（医学版）,2006,26(2):273-276. 被引量：3
  • 2Zheng Y,Zhang J, Xu Z, et al. Quantitative profiles of the mRNA of ER-α and its novel variant ER-α36 in breastcancers and matched normal tissues[ J ]. J Zhejiang Univ- Sci B ( Biomed & Biotechnol), 2010,11 ( 2 ) : 144 - 150.
  • 3Lin SL, Yan LY, Zhang XT, et al. ER-α36, a variant of ER-α, promotes tamoxifen agonist action in endometrial cancer cell via the MAPK/ERK pathways [J]. PLOS ONE,2009,5 (2) :9013.
  • 4Shi L, Dong B, Lu Y, et al. Expression of ER-a36,a novel variant of estrogen receptor α,and resistance to tamioxifen treatment in breast cancer [J].J Clin Oneol, 2009,27 : 3423 -3429.
  • 5Friedrichs K, Gluba S, Eidtmann H, et al. Overexpression of p53 and prognosis in breast cancer[J]. Cancer, 1993, 72(12) :3641-3647.
  • 6Wang Z, Zhang X, Shen P, et al. Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of hmnan estrogen receptor-alpha66 [ J].Biochemical and Biophysical Research Communications, 2005,336 : 1023-1027.
  • 7Lee LM, Cao J, Deng H, et al. ER-alpha36, a novel variant of ER-alpha,is expressed in ER-positive and-negative human breast carcinoma[J]. Antieancer Res,2008,28:479- 483.
  • 8Wang Z,Zhang X, Shen P, et al. A variant of estrogen receptor- / alpha / , hER- / alpha / 36 : transduetion of estrogen and antiestrogen-dependent membrane-lnitiated mitogenic signaling[J]. Proceedings of the National Academy of Sciences of the United States of America, 2006,103 : 9063- 9068.
  • 9Zhang LL,Li XP,Zhao LJ, et al. Nongenomic effect of estrogen on the MAPK signaling pathway and calcium influx in endometrial carcinoma cells [ J ]. J Cellular Biochemistry,2009,106(4) :553-562.
  • 10Coulombe P, Meloche S. Atypical mitogen-activated protein kinases : structure, regulation and functions [ J ]. Biochim Biophys Acta,2007,1773 ( 8 ) : 1376-1387.

共引文献9

同被引文献33

  • 1董桂芝,梁晓玲,彭辉,王玲,王建文,杜朝晖,张丽.威海市1636例乳腺癌预后多因素分析[J].中华临床医师杂志（电子版）,2011,5(20):6012-6016. 被引量：3
  • 2孙燕,周际昌临床肿瘤内科手册[M].第3版.北京:人民卫生出版社,1997,30:45.
  • 3Blows FM, Driver KE, Schmidt MK, et al. Subtyping of breast cancer by immunohisto-chemistry to investigate a relationship between subtype and short and long term survival : A collabora- tive analysis of data for 10,159 cases from 12 studies [J]. PLoS Med ,2010,7 : e1000279.
  • 4Wong M, O'Neill S, Walsh G, et al. Goserelin with chemother- apy to preserve ovarian function in pre-menopausal women with early breast cancer:menstruation and pregnancy outcomes[J]. Annals of Oncology,2013,24( 1 ) : 133-138.
  • 5Lee S, Schover L, Partridge A, et al. American Society of Clin- ical Oncology recommendations on fertility preservation in cancer patients [J]. Clin Onco1,2006,24 ( 18 ) :2917-2931.
  • 6Petru E, Wildt L, Stummvoll W, et al. Konsensus der oster- reichischen gesellschaft fur gynakologie und geburtshilfe (OEGGG)/arbeitsgemeinschaft fur gynakologische onkologie [J]. Geburtsh Frauenheilk ,2009,69 ( 12 ) : 1071-1077.
  • 7Wu S, Li Q, Zhu Y, et al. Role of goserelin in combination with endocrine therapy for the treatment of advanced breast cancer in premenopausal women positive for hormone recep- tor: a retrospective matched case-control study [ J ]. Cancer Biother Radiopharm, 2013,28 ( 10 ) : 697-702.
  • 8Gradishar W. Landmark trials in endocrine adjuvant therapy for breast carcinoma[ J]. Cancer,2006,106 ( 5 ) :975-981.
  • 9Wang QP,Wang Y,Wang XD,et al.Survivin up-regulates the expression of breast cancer resistance protein(BCRP)through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells[J].Int J Biochem Cell Biol,2013,45(9):2036-2044.
  • 10Cui Y,Rohan TE.Vitamin D,calcium and breast cancer risk:a review[J].Cancer Epidemiol Biomarkers Prev,2006,15(8):1427-1437.

引证文献3

二级引证文献11

中国医师杂志
2013年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部